Method of treating actinic keratosis with 3.75% imiquimod cream
作者： Valyn S. Bahm , Robert Babilon , Kodumudi S. Balaji , Sharon F. Levy , Jason J. Wu
DOI:
关键词: Dermatology 、 Medicine 、 Dosing regimen 、 Actinic keratosis 、 Drug administration 、 Transdermal 、 Imiquimod 、 Safety profile 、 Dosing
摘要: Pharmaceutical formulations and methods for the topical or transdermal delivery of 1-isobutyl-1H-imidazo[4,5-c]-quinolin-4-amine 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine, i.e., imiquimod, to treat actinic keratosis with short durations therapy, than currently prescribed commercially available ALDARA 5% imiquimod cream, as now approved by U.S. Food & Drug Administration (“FDA”), are disclosed described. More specifically, lower dosage strength deliver an efficacious dose treating acceptable safety profile dosing regimens that more convenient patient use regimen (“FDA”) cream also
google.de 参考文章(138)
Del Rosso Jq, The use of topical imiquimod for the treatment of actinic keratosis: a status report. Cutis. ,vol. 76, pp. 241- 248 ,(2005)
Michael Shaffelburg, Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream. Journal of Drugs in Dermatology. ,vol. 8, pp. 35- ,(2009)
Sandra Sacre, Brian M. Foxwell, Treatments for inflammatory arthritis ,(2008)
Howard Murad, Pharmaceutical compositions and methods for managing dermatological conditions ,(2002)
Norman M. Price, The treatment of actinic keratoses with a combination of 5-fluorouracil and imiquimod creams. Journal of Drugs in Dermatology. ,vol. 6, pp. 778- 781 ,(2007)
Berman B, Villa Am, Poochareon Vn, Novel dermatologic uses of the immune response modifier imiquimod 5% cream. Skin therapy letter. ,vol. 7, pp. 1- 6 ,(2002)
Girish S. Munavalli, Tze-Chiang Meng, Michael H. Gold, Joel L. Cohen, Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis ,(2012)
Patrick J. Roddy, Terri F. Busch, Janet A. Vallejo, Suzanne S. Leung, Immune response modifier formulations ,(2007)
Amit Munshi, Novel delivery of immune response modifiers for removal of chronic tattoos ,(2006)
Jochen Probst, Ingmar Hoerr, Soehnke Voss, Thomas Kramps, Nucleic acids of formula(i)(nuglxmgnnv)a and derivatives thereof as an immunostimulating agent /adjuvant ,(2009)